13‐1194(L)
GAMCO v. Vivendi
UNITED STATES COURT OF APPEALS
FOR THE SECOND CIRCUIT
August Term 2015
(Argued: March 3, 2016 Decided: September 27, 2016)
No. 13‐1194(L), 13‐1377(XAP)
––––––––––––––––––––––––––––––––––––
GAMCO INVESTORS, INC., GAMCO GLOBAL SERIES FUNDS, INC., GABELLI CAPITAL
ASSET FUND, THE GABELLI VALUE FUND, INC., THE GABELLI ASSET FUND, THE
GABELLI GLOBAL MULTIMEDIA TRUST INC., THE GABELLI EQUITY TRUST, INC.,
Plaintiffs‐Appellants‐Cross‐Appellees,
THE GAMCO MATHERS FUND, THE GABELLI CONVERTIBLE AND INCOME SECURITIES
FUND, INC., GAMCO INTERNATIONAL GROWTH FUND, INC.
Plaintiffs,
‐v.‐
VIVENDI UNIVERSAL, S.A., VIVENDI S.A.,
Defendants‐Appellees‐Cross‐Appellants.
––––––––––––––––––––––––––––––––––––
Before: CABRANES, LIVINGSTON, and LYNCH, Circuit Judges.
1
Plaintiffs‐Appellants‐Cross‐Appellees, so‐called “value investors,” appeal
from the judgment of the United States District Court for the Southern District of
New York (Scheindlin, J.), granting judgment to the Defendants because they
had rebutted the fraud‐on‐the‐market presumption of reliance invoked by the
Plaintiffs as part of their claim under § 10(b) of the Securities Exchange Act of
1934, 15 U.S.C. § 78j(b). For the reasons stated below, we AFFIRM the
judgment of the district court.
ANDREW J. ENTWISTLE, Entwistle & Cappucci LLP, New
York, N.Y. (Vincent R. Cappucci, Arthur V. Nealon,
Jordan A. Cortez, Entwistle & Cappucci LLP, New
York, N.Y., on the brief), for
Plaintiffs‐Appellants‐Cross‐Appellees.
MARK A. PERRY, Gibson, Dunn & Crutcher LLP,
Washington, D.C. (Miguel A. Estrada, Lucas C.
Townsend, Gibson, Dunn & Crutcher LLP, Washington,
D.C.; Caitlin J. Halligan, Gabriel K. Gillett, Gibson,
Dunn & Crutcher LLP, New York, N.Y.; James W.
Quinn, Gregory Silbert, Weil, Gotshal & Manges LLP,
New York, N.Y.; Daniel Slifkin, Timothy G. Cameron,
Cravath, Swaine & Moore LLP, New York, N.Y., on the
brief), for Defendants‐Appellees‐Cross‐Appellants.
PER CURIAM:
This appeal stems from the same set of underlying facts as those in In re
Vivendi S.A. Securities Litigation, Nos. 15‐180‐cv(L), 15‐208‐cv(XAP), in which we
have today issued a separate opinion. Plaintiffs‐Appellants‐Cross‐Appellees
(collectively, “GAMCO”) are so‐called “value investors” who make their own
estimation of the value of a publicly‐traded company’s securities and attempt to
2
buy such securities when the market price is lower than its own valuation, betting
that the market price will rise over time. Between 2000 and 2002, GAMCO
invested in the securities of Defendants‐Appellees‐Cross‐Appellants Vivendi
Universal, S.A. and Vivendi S.A. (collectively, “Vivendi”). Thereafter, when the
nature of Vivendi’s liquidity situation came to light, the price of those securities
dropped dramatically.
GAMCO subsequently brought a securities fraud action against Vivendi
under § 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”), 15 U.S.C.
§ 78j(b), as well as the Securities Exchange Commission’s (“SEC”) Rule 10b–5
(“Rule 10b–5”) promulgated thereunder, 17 C.F.R. § 240.10b–5. After a bench
trial solely on the question whether Vivendi successfully rebutted the
fraud‐on‐the‐market presumption of reliance invoked by GAMCO to satisfy the
reliance element of its § 10(b) claim, see Basic Inc. v. Levinson, 485 U.S. 224, 247
(1988), the District Court for the Southern District of New York (Scheindlin, J.)
entered judgment for Vivendi. See GAMCO Investors, Inc. v. Vivendi, S.A., 927 F.
Supp. 2d 88, 91 (S.D.N.Y. 2013) (“GAMCO”). GAMCO now appeals.1
1 Vivendi also cross‐appeals from the district court’s determination that Vivendi
was barred by collateral estoppel from contesting the other elements of GAMCO’s
§ 10(b) claim. Because we affirm the district court’s decision in favor of Vivendi, we
need not reach this claim.
3
DISCUSSION
“On appeal from a bench trial, the district courtʹs findings of fact are
reviewed for clear error and its conclusions of law are reviewed de novo.” Beck
Chevrolet Co., Inc. v. Gen. Motors LLC, 787 F.3d 663, 672 (2d Cir. 2015) (quoting
Mobil Shipping & Transp. Co. v. Wonsild Liquid Carriers Ltd., 190 F.3d 64, 67 (2d Cir.
1999)).
To succeed on a § 10(b) and Rule 10b–5 claim, a plaintiff must prove “(1) a
material misrepresentation or omission by the defendant; (2) scienter; (3) a
connection between the misrepresentation or omission and the purchase or sale of
a security; (4) reliance upon the misrepresentation or omission; (5) economic loss;
and (6) loss causation.” Halliburton Co. v. Erica P. John Fund, Inc., 134 S. Ct. 2398,
2407 (2014) (quoting Amgen Inc. v. Conn. Retirement Plans and Tr. Funds, 133 S. Ct.
1184, 1192 (2013)). The traditional way a plaintiff demonstrates reliance is
directly, i.e. “by showing that he was aware of a company’s statement and
engaged in a relevant transaction . . . based on that specific misrepresentation.”
Id. (quoting Amgen, 133 S. Ct. at 1192)). However, a plaintiff may, in some
circumstances, invoke a “rebuttable presumption of reliance.” Id. at 2408. This
presumption rests on the “‘fraud‐on‐the‐market’ theory” which states “that ‘the
4
market price of shares traded on well‐developed markets reflects all publicly
available information, and, hence, any material misrepresentations.’” Id.
(quoting Basic, 485 U.S. at 246). Because “the typical ‘investor who buys or sells
stock at the price set by the market does so in reliance on the integrity of that
price’—the belief that it reflects all public, material information— . . . his ‘reliance
on any public material misrepresentations . . . may be presumed for purposes of a
Rule 10b–5 action.’” Id. (quoting Basic, 485 U.S. at 247). But the presumption, as
its name suggests, is rebuttable.2 “Any showing that severs the link between the
alleged misrepresentation and either the price received (or paid) by the plaintiff,
or his decision to trade at a fair market price, will be sufficient to rebut the
presumption . . . .” Id. (quoting Basic, 485 U.S. at 248) (alteration omitted).
As an initial matter, GAMCO argues that the District Court “erred in
concluding that . . . because Vivendi demonstrated that Plaintiffs are value
investors[,] Vivendi . . . proved [GAMCO] did not rely on the integrity of the
2 To demonstrate successfully that the presumption should apply in a given case,
“a plaintiff must [show] . . . (1) that the alleged misrepresentations were publicly known,
(2) that they were material, (3) that the stock traded in an efficient market, and (4) that
the plaintiff traded the stock between the time the misrepresentations were made and
when the truth was revealed.” Id. It was not contested at the trial that the
presumption itself applied, only whether it had been rebutted.
5
market in purchasing Vivendi [securities].” GAMCO Br. at 41. According to
GAMCO, though it, like most value investors, does not believe that the market
price necessarily equals, at any given time, the efficient value of a security (and
thus makes its money by identifying under‐ or over‐valued securities), Halliburton
forecloses the conclusion that this fact alone suffices to rebut the presumption.3
Vivendi, for its part, suggests that such a showing indeed suffices to rebut the
presumption. See Vivendi Br. at 33; cf. Teamsters Loc. 445 Freight Div. Pension Fund
v. Bombardier Inc., 546 F.3d 196, 199 n.4 (2d Cir. 2008) (“The . . .
fraud‐on‐the‐market theory involves [the] rebuttable presumption[] . . .
‘that . . . investors rely on the market price of securities as an accurate measure of
their intrinsic value.’” (quoting Hevesi v. Citigroup Inc., 366 F.3d 70, 77 (2d Cir.
2004)).
It is true that the district court reasonably found facts that demonstrate that
GAMCO’s purchasing decisions relied in large part on an independent valuation
3 See Halliburton, 134 S. Ct. at 2410 (“Debates about the precise degree to which
stock prices accurately reflect public information are . . . largely beside the point.”); id. at
2411 (noting that “there is no reason to suppose that . . . the value investor[] is as
indifferent to the integrity of market prices as Halliburton suggests”); but see id. (noting
that “Basic never denied the existence of [value] investors,” as “Basic concluded only that
‘it is reasonable to presume that most investors . . . will rely on the security’s market price
as an unbiased assessment of the security’s value in light of all public information.’”
(quoting Amgen, 133 S. Ct. at 1192)).
6
of the worth of Vivendi’s securities that was separate and distinct from the market
price. The district court found that GAMCO would begin by calculating a
“Private Market Value[]” (“PMV”) for a given security — a value that
approximated “the price that an informed industrialist would be willing to pay
for [the company], if each of its segments were valued independently in a private
market sale.” GAMCO, 927 F. Supp. 2d at 94–95. GAMCO would then
compare this PMV to the public market price. If there was a sufficiently large
“spread between [the] PMV and the market price,” and if there was evidence of
the existence of a “catalyst,” id. at 94–96, or “some dynamic that [GAMCO
thought was] going to help surface value over time,” J.A. 359, then GAMCO
would generally elect to purchase the security in question. Employees at
GAMCO often referred to its PMV as the “intrinsic value” of the stock, see, e.g.,
J.A. 338, 508, and frequently referred to the market price, in contrast, as reflecting
the whims of the sometimes “irrational . . . Mr. Market,” J.A. 358.
Though the district court indeed found that GAMCO does not necessarily
consider the market price to be an efficient reflection of the objective value of a
security at any given time, however, it explicitly disclaimed any reading of its
opinion as suggesting that this fact was sufficient, on its own, to rebut the
7
presumption. See GAMCO, 927 F. Supp. 2d at 102 (“[O]ne can imagine a case
where an investor . . . used the market price of a security merely as a comparator
with a private method of valuation, but in which the fraud on the market
presumption could not fairly be rebutted, because, but for the material
misstatements, that investor would not have transacted in the securities at
issue.”). We thus decline to explicate the contours of Halliburton here, further
theorize on the presumption, or otherwise address the relevance of the typical
value investing model to a rebuttal showing. The district court’s holding was,
instead, based on a much narrower theory: that, given the facts in the record,
Vivendi proved that GAMCO would have purchased Vivendi securities even had
it known of Vivendi’s alleged fraud. See Halliburton, 134 S. Ct. at 2408 (observing
that a defendant may rebut the presumption by demonstrating, inter alia, “that a
plaintiff would have bought or sold the stock even had he been aware that the
stock’s price was tainted by fraud”); Kline v. Wolf, 702 F.2d 400, 403 (2d Cir. 1983)
(noting that the presumption may be rebutted through a showing “that plaintiffs
did not significantly rely on the integrity of the market or that, even if they had
known of the alleged misrepresentation, they would still have purchased the
stock”).4 GAMCO argues that this factual conclusion was error, and asserts that
4 The district court found facts sufficient to establish that that it was more likely
8
“[i]t was clearly erroneous for the District Court to find that a sophisticated
financial manager would purchase securities in advance of undisclosed adverse
information which would have the predic[t]able impact of causing market prices
than not that GAMCO would have purchased the relevant securities even if it had
known that Vivendi’s statements were misrepresenting its liquidity. See GAMCO, 927
F. Supp. 2d at 97 (finding, inter alia, that “the liquidity crisis at Vivendi was irrelevant to
Plaintiffs’ investment decisions”). Nevertheless, GAMCO takes issue with the district
court’s approach to determining whether GAMCO would have purchased the security
even if it had known there was a fraud. Specifically, GAMCO questions the district
court’s reliance on the argument that GAMCO would have considered Vivendi’s
securities a more attractive investment had Vivendi fully divulged its liquidity problems
to the entire market prior to GAMCO’s purchase. See id. at 102 (where the district
court observes that “in this counterfactual scenario [where Vivendi did not commit any
fraud] . . . the price of Vivendi ADS’s would have been lower” as the market price
would have fallen with revelation of the truth, and thus “Plaintiffs would have seen
Vivendi as a more attractive investment”). GAMCO does not necessarily question the
premise that, if Vivendi had fully disclosed its liquidity problems to the market, then
the market would likely have internalized the value of those problems, the stock’s price
would have fallen, and the spread between the PMV and the market price would thus
have been larger. Nor does GAMCO deny that it may have purchased the security at
this lower price had there been no fraud at all. Rather, GAMCO contests the relevance
of the district court’s inquiry to what GAMCO believes is the central issue, namely
whether GAMCO would have purchased shares “at the same price[]” had it been aware
that many of Vivendi’s statements were fraudulent. Id. at 103 (emphasis added)
(internal quotation marks omitted); see also Halliburton, 134 S. Ct. at 2408 (noting that a
defendant may rebut the presumption by showing “that a plaintiff would have bought
or sold the stock even had he been aware that the stock’s price was tainted by fraud”).
Though we observe that GAMCO’s framing of the appropriate inquiry has much
to recommend it, we need not conclusively endorse it here. Even adopting, arguendo,
GAMCO’s preferred framing, see GAMCO Br. at 27 n.11 (acknowledging that the
presumption may be rebutted by showing that a “plaintiff would have purchased the
stock at the same price even if she had known of the fraud”), the district court did not
clearly err in concluding, as detailed herein, that revelation of Vivendi’s liquidity
problems would not have changed GAMCO’s purchasing decisions.
9
to decline.” GAMCO Reply Br. at 8. Our review of the record demonstrates
that it was not “clearly erroneous” for the district court to so conclude as to
GAMCO itself. Under that deferential standard of review, we must accept the
district court’s findings of fact “unless we have a definite and firm conviction
that a mistake has been committed.” Souratgar v. Lee, 720 F.3d 96, 103 (2d Cir.
2013) (internal quotation marks omitted). We therefore need not, and do not,
decide whether we would have reached the same factual conclusions as the
district court.
First, though GAMCO repeatedly asserts on appeal that it is all but
unthinkable that a sophisticated investor would ever buy a security if he was
aware its market price might be tainted by fraud, the idea was not so ridiculous
to the Chief Investment Officer of Gabelli & Co. Asked whether he would “buy
a stock in a company . . . [where he] knew . . . the price was inflated as a result of
a management fraud,” Mario Gabelli testified that such a purchase was
“possible, but very unlikely,” and clarified that he would “assign a 90‐10
probability” to such a scenario. J.A. 530–31. He went on to qualify this
statement, noting “[t]here would have to be a lot of other circumstances.” Id. at
531. The district court largely dismissed Gabelli’s testimony as “motivated
10
hairsplitting by an interested witness.” GAMCO, 927 F. Supp. 2d at 94. It is
thus highly significant that a prominent witness the district court believed was
exaggerating the facts in favor of the plaintiffs admitted on the stand that, in the
abstract, there was a ten percent possibility that, in a given case, he would buy
stock inflated by fraud. Such testimony, at minimum, established — in contrast
to GAMCO’s repeated suggestions — that GAMCO had no ironclad policy
against purchasing a stock it believed might be inflated by fraud, provided that
other circumstances made the deal one worth pursuing.
To that end, the record in this case includes sufficient evidence supporting
the district court’s finding that such circumstances were present here: in other
words that, even if aware of Vivendi’s liquidity problems and its concealment of
those problems, GAMCO would still have believed the deal it made was a good
one. As already noted, the district court reasonably found that the core of
GAMCO’s investment decisions could be reduced to two questions: first, was
there a material spread between market price and PMV, and second, was there
reason to believe a catalyst would cause the market to recognize this discrepancy
in the next two to five years. Evidence in the record also supported the district
court’s conclusion that, had GAMCO known of the liquidity problems at Vivendi,
11
such knowledge would not have altered the answers to either of these questions.
As to the spread, Andrew Rittenberry, the analyst primarily responsible for
calculating Vivendi’s PMV in the relevant period, testified that, once he learned of
the liquidity crisis at Vivendi (as the fraud came to light), the knowledge of the
liquidity problems had no “impact [on his] PMV calculation,” as he believed
those problems constituted “a short‐term issue . . . . [s]omething that could be
solved within a year or so.” J.A. 401‐03. Rittenberry also testified that PMV was
generally calculated to anticipate the value of the company over the long haul.
This testimony further supports the district court’s factual finding that GAMCO
would not have believed that a short‐term problem, especially one that it did not
perceive to be as significant as the market ultimately came to believe it was,
would affect its calculation of the spread. See J.A. 368 (noting that, in calculating
the PMV, Rittenberry “projected the business performance of [the] differen[t]
pieces of the business over a five‐year period”); J.A. 383 (“[T]he goal in buying a
stock is to have it appreciate 50 percent over a two‐year period”); J.A. 527
(testimony of Mario Gabelli: “So the way we think is like a McKinsey thinking
out over the next five or ten years”). Thus, the record supports the district
court’s conclusion that, if GAMCO had known of the liquidity problems and
12
their concealment, GAMCO would still have believed Vivendi’s PMV to be
“materially higher” than the public market price. J.A. 363.
Second, it was also not clearly erroneous for the district court to conclude
that knowledge of Vivendi’s liquidity problems would not have changed
GAMCO’s belief that a catalyst was likely — i.e., its belief that the market price
would rise towards the PMV, if not immediately, then over the course of the next
several years. Such evidence came in various forms. First, GAMCO continued
to buy Vivendi securities as the full extent of Vivendi’s alleged fraud came to
light. GAMCO argues that this information is hardly dispositive of whether
GAMCO would have purchased prior to the revelation of the fraud at the same
price at which it purchased (given that the revelation caused the market price to
fall as fraud‐induced inflation dissipated). That may indeed be so, but the
evidence is specifically relevant to the narrower question whether knowledge of
the liquidity problems would have affected GAMCO’s belief in the existence of a
catalyst. That GAMCO continued to buy reasonably suggested to the district
court that GAMCO still believed a catalyst to be on the horizon (and thus
demonstrated that the liquidity problems had not altered, and would not have
altered, this conclusion). Further, Gabelli testified that a “change of
13
management” was one of the most frequent catalysts on which GAMCO would
rely in purchasing a stock. J.A. 482. This testimony further reinforced the
district court’s factual findings: had GAMCO known of the liquidity problems at
Vivendi (notwithstanding whether they had been fraudulently concealed), the
potential for a change in management would have seemed even more likely.
In short, evidence in the record supported the district court in concluding
that, had GAMCO known of Vivendi’s liquidity problems, GAMCO would still
have believed, first, that Vivendi’s securities were substantially undervalued by
the market and second, that an event was likely to happen in the next few years
that would awaken the market to that fact. Further, the record provided
sufficient evidence to find that GAMCO would have believed that, even if the
liquidity crisis in fact came to light, it would resolve within a short period of
time — and thus, that even if the market price might go down in the short run,
the potential for long‐term profit still remained. In other words, whereas one
can imagine situations in the abstract where a sophisticated investor, apprised of
a fraud, would necessarily conclude that a security was no longer a logical
purchase, the district court did not clearly err in concluding, on this record, that
in this case, and with regard to this particular fraud, GAMCO would still have
14
viewed Vivendi’s securities as a profitable investment — even if it might have
been concerned about the hidden liquidity risks.
GAMCO counters this extensive evidence by citing, almost exclusively, to
testimony of Andrew Rittenberry, which GAMCO employs to argue that the
district court’s factual findings were clearly erroneous. Asked whether,
assuming the information “did not affect [his] PMV calculation, a liquidity crisis
would similarly not affect [his] buy, sell, or hold recommendation,” Rittenberry
replied, “[n]o, not necessarily.” J.A. 401. “The big driver,” he continued, “[is]
PMV. But the discount to the PMV between the market price and the PMV is a
key factor. If there is a liquidity crisis or some type of event like that, you
would expect the discount to widen. I mean you would expect the stock to go
down.” Id. When further asked whether he “would expect the public market
price to go down,” Rittenberry answered, “[y]es. You wouldn’t want to buy it
in front of that — if you thought it was going to go down, you would wait to buy
it or buy more or recommend to buy more at that point.” Id.
Pointing to Rittenberry’s testimony, GAMCO argues that even if it would
not have believed the liquidity problems to affect Vivendi’s PMV, and even if it
would still have believed it likely the investment would be profitable over the
15
long run, the record renders clearly erroneous the district court’s finding that it
would have purchased Vivendi’s securities had it known of the fraud. This is
because, GAMCO argues, even if it indeed still thought Vivendi securities were
materially undervalued notwithstanding the crisis, it would have waited until
the liquidity crisis came to light and then bought the stock. Such a delayed
purchase not only would have mitigated the risk associated with the undisclosed
liquidity problems (as fraud always creates some risk that the underlying
calculations are erroneous), but also would have potentially netted GAMCO a
more profitable investment.
It was not clearly erroneous, however, for the district court to find that
GAMCO would indeed have purchased Vivendi’s securities at the price quoted,
rather than simply await the potential of a public liquidity crisis. First, both
Rittenberry’s testimony and GAMCO’s argument rest on the assumption that
Rittenberry (and GAMCO) would have known that the stock price would indeed
go down upon revelation of the liquidity crisis. As already noted, however, the
district court reasonably found facts demonstrating that Rittenberry, or GAMCO,
apprised of the hidden liquidity risks, would not have been so certain. At the
time GAMCO had to make its purchasing decision, even if it had known of the
16
fraud, it would not have been able to see the future. And the record evidence as
to how GAMCO would have approached determining how likely it was that the
hidden risks would be exposed in a way that would materially affect the market
price does not support GAMCO’s position.
Thus, Rittenberry testified that, when he did find out about the liquidity
problems, he believed that they constituted a very short‐term concern with
minimal impact on Vivendi’s value. It was therefore not clearly erroneous for
the district court to infer that GAMCO, privy to this information prior to its
relevant purchases, would have believed it possible that the crisis would pass
without incident or public revelation, or at minimum be uncertain as to just how
the market would value the crisis were it to come to light. Given that the record
makes clear that GAMCO would, in at least some circumstances, have purchased
a security even believing it was tainted by fraud, it is highly relevant that the
record also provides sufficient evidence to find that GAMCO would have
believed this particular fraud unlikely to become material.
Further, against this uncertainty of a future, hypothetical better deal, the
record provided evidence that GAMCO had reasons to believe the deal — which,
as already noted, would have appeared to be a good one — could get worse if
17
GAMCO waited. As Rittenberry testified, the premise of GAMCO’s model was
that it found a stock was “trad[ing] at a discount to what [GAMCO believed] it[]
[was] worth temporarily,” and that “that discount [would] . . . narrow over time.”
J.A. 357 (emphasis added). As a general matter, then, to wait, rather than buy
the stock, always risked the possibility that the prophesied catalyst would come
early, or that the market would recognize that the value of the stock was
depreciated. Further, Gabelli testified that he believed the market, in the
aggregate, to be “down sharply” by the beginning of 2001, J.A. 522, and in
GAMCO’s December 2000 Annual Report to investors, it “forecast . . . an
economic (and earnings) recovery” in “the second half of 2001” which would
“help[] . . . renew investor confidence and revive the market,” J.A. 591. To wait
for the hypothetical revelation of the liquidity problems, then, would risk not
only that the market, specifically, would realize that Vivendi’s stock was
undervalued, but also that the market, generally, would rebound and the market
price would rise accordingly, sacrificing the spread. It was not clearly
erroneous for the district court to conclude that GAMCO, aware of the fraud,
would not have waited to buy the securities.
In other words, the premise of Rittenberry’s testimony, and GAMCO’s
18
argument, assumes what it seeks to prove: that GAMCO would have known that
the liquidity problems would manifest in the way that, in hindsight, they
manifested, and would thus obviously have waited to buy if it purchased at all.
But the district court’s rejection of that conclusion was not clearly erroneous.
Further, GAMCO exaggerates the probative value of Rittenberry’s testimony in
another way as well. Even on its own terms, Rittenberry’s testimony does not
clearly suggest that GAMCO would not have bought if it had known of the
hidden liquidity risks. Asked whether knowledge of such a hidden crisis
would “not affect” his buy or sell recommendation, Rittenberry, not unlike
Gabelli, answered equivocally: “no, not necessarily.” J.A. 401 (emphasis added).
And, when describing what his recommendation would be, he did not say that he
would recommend that GAMCO not buy; instead, he testified that “if [he]
thought [the market price] was going to go down, [he] would wait to buy it or
buy more or recommend to buy more at that point.” Id. (emphasis added). In other
words, the district court did not have to read this testimony as GAMCO reads it.
Instead, it could reasonably have read Rittenberry’s testimony as suggesting that
GAMCO would buy and then wait and buy more if indeed the liquidity problems
surfaced. Such an approach would potentially allow GAMCO to ensure it
19
captured a good deal when it saw one while hedging against the possibility of an
uncertain future.
It may seem unlikely, in the abstract, that an investor, aware of fraud,
would opt to purchase a given security. Nevertheless, after a trial, we do not
review a district court’s factual findings for whether they seem, in the abstract,
correct — we review the record for sufficient evidence in support of those
judgments. And here, the record at the trial simply does not establish that it
was clearly erroneous for the district court to find that GAMCO, had it known of
the liquidity problems at Vivendi, would have made the choice to buy the same
securities it purchased.5
5 We also conclude that GAMCO’s challenge to the district court’s grant of
summary judgment is unreviewable. GAMCO concedes that we do not have
jurisdiction to hear an appeal from a denial of summary judgment after a trial, unless
the “district court’s error was purely one of law.” Stampf v. Long Island R.R. Co., 761
F.3d 192, 201 n.2 (2d Cir. 2014); see GAMCO Reply Br. at 31–32. GAMCO further
acknowledges that one ground on which the district court denied summary judgment
was its finding that “GAMCO could possibly have uncovered non‐public corrective
information which would rebut the presumption of reliance.” GAMCO Br. at 9; see also
J.A. 92. GAMCO concedes that, as a legal matter, this scenario does indeed rebut the
presumption of reliance. See GAMCO Br. at 27 n.11 (noting that one of the
“recognized ways to rebut the . . . presumption [is when] plaintiff possessed non‐public
information concerning the fraudulent misstatements.”). GAMCO argues that
evidence in the record created no material question of fact, at summary judgment,
whether GAMCO had such information. This argument misses the point. To the
degree that GAMCO agrees with the legal standard the district court applied
(non‐public corrective information can rebut the presumption of reliance) and argues
only that the district court erred in finding a material question of fact pursuant to that
20
CONCLUSION
Accordingly, and finding no merit in the Plaintiffs’ remaining arguments,
we AFFIRM the judgment of the District Court.
legal standard, at least one ground for the district court’s denial of summary judgment
was not a pure error of law, but one of fact. Thus, the denial is not reviewable by this
Court. See Stampf, 761 F.3d at 201 n.2.
21